Alexander Roeth

Prognostic impact of meningeal dissemination in primary CNS lymphoma (PCNSL): experience from the G-PCNSL-SG1 trial

Agnieszka Korfel, Michael Weller, Peter Martus et al. · Annals of Oncology · 2012 · 67 citations

Medicine, Neurology, Oncology +10

Effects on Survival of Non-Myeloablative Chemoimmunotherapy Compared to High-Dose Chemotherapy Followed By Autologous Stem Cell Transplantation (HDC-ASCT) As Consolidation Therapy in Patients with Primary CNS Lymphoma - Results of an International Randomized Phase III Trial (MATRix/IELSG43)

Gerald Illerhaus, Andrés J.M. Ferreri, Mascha Binder et al. · Blood · 2022 · 44 citations · Full text

Medicine, Oncology, Chemotherapy +14

Imetelstat Rapidly Induces and Maintains Substantial Hematologic and Molecular Responses in Patients with Essential Thrombocythemia (ET) Who Are Refractory or Intolerant to Prior Therapy: Preliminary Phase II Results

Gabriela M. Baerlocher, Elisabeth Oppliger Leibundgut, Christina Ayran et al. · Blood · 2012 · 23 citations

Medicine, Hematology, Pharmacology +6

Sequential High Dose Immuno-Chemotherapy Followed by Autologous Peripheral Blood Stem Cell Transplantation for Patients with Untreated Primary Central Nervous System Lymphoma - a Multicentre Study by the Collaborative PCNSL Study Group Freiburg

Gerald Illerhaus, Kristina Fritsch, Gerlinde Egerer et al. · Blood · 2012 · 22 citations

Medicine, Immunology, Oncology +12

Oral Monotherapy with Iptacopan, a Proximal Complement Inhibitor of Factor B, Has Superior Efficacy to Intravenous Terminal Complement Inhibition with Standard of Care Eculizumab or Ravulizumab and Favorable Safety in Patients with Paroxysmal Nocturnal Hemoglobinuria and Residual Anemia: Results from the Randomized, Active-Comparator-Controlled, Open-Label, Multicenter, Phase III Apply-PNH Study

Régis Peffault de Latour, Alexander Roeth, Austin Kulasekararaj et al. · Blood · 2022 · 22 citations

Medicine, Pharmacology, Pharmacotherapy +16